Residents of Guinea's western city of Kindia were among the first to get vaccinated with a new Russian-developed Ebola vaccine at the Centre for Epidemic and Microbiological Research and Treatment (CEMRT) on Wednesday, as part of an ongoing clinical trial. Footage released on Thursday shows people volunteering to receive the world's first Ebola shots administered since the region's 2014 epidemic... Еще, which claimed the lives of some 2,535 people. The first 1,000 doses of the Russian Ebola vaccine were sent to Guinea in July 2017. The vaccine, named 'Gam Evak Combi', was developed by Russian scientists from the Gamaleya Research Institute of Epidemiology and Microbiology, and had about 1,000 people involved in its clinical trial. CEMRT was set up by Russian aluminium company RUSAL, which has acted as one of the largest foreign investors in the country since 2011. Russian President Vladimir Putin authorised the development of the Gam Evak Combi following a request made by President of Guinea Alpha Conde, at the end of 2014. According to the WHO, over 28,000 people have been infected worldwide by Ebola since December 2013, with 11,000 people dying as a result. The most recent outbreak began in Guinea before spreading to Liberia and Sierra Leone.